<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="70" ids="18291,35154">Manganese</z:chebi> ions block <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of phagocytes induced by various agents </plain></SENT>
<SENT sid="1" pm="."><plain>The prevention of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was attributed to the activation of manganous <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (Mn-SOD) and to the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> function of free <z:chebi fb="0" ids="29035">Mn2+</z:chebi> <z:chebi fb="36" ids="36916">cations</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the effect of <z:chebi fb="0" ids="29035">Mn2+</z:chebi> on B cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is not documented </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated the effects of <z:chebi fb="0" ids="29035">Mn2+</z:chebi> on the apoptotic process in human B cells </plain></SENT>
<SENT sid="4" pm="."><plain>We observed that <z:chebi fb="0" ids="29035">Mn2+</z:chebi> but not Mg2+ or <z:chebi fb="0" ids="29108">Ca2+</z:chebi>, inhibited cell growth and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of activated tonsilar B cells, Epstein Barr virus (EBV)-negative Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-CL) and EBV-transformed B cell lines (EBV-BCL) </plain></SENT>
<SENT sid="5" pm="."><plain>In the same conditions, no <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was observed in U937, a monoblastic cell line </plain></SENT>
<SENT sid="6" pm="."><plain>Induction of B cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by <z:chebi fb="0" ids="29035">Mn2+</z:chebi> was time- and dose-dependent </plain></SENT>
<SENT sid="7" pm="."><plain>The cell permeable <z:chebi fb="0" ids="47923">tripeptide</z:chebi> inhibitor of ICE family cysteine proteases, zVAD-fmk, suppressed <z:chebi fb="0" ids="29035">Mn2+</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, <z:chebi fb="0" ids="29035">Mn2+</z:chebi> triggered the activation of interleukin-1beta converting enzyme (ICE/caspase 1), followed by the activation of CPP32/Yama/Apopain/caspase-3 </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, poly-(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase (PARP), a cellular substrate for CPP32 protease was degraded to generate apoptotic fragments in <z:chebi fb="0" ids="29035">Mn2+</z:chebi>-treated B cell lines </plain></SENT>
<SENT sid="10" pm="."><plain>The inhibitor, zVAD-fmk suppressed <z:chebi fb="0" ids="29035">Mn2+</z:chebi>-triggered CPP32 activation and PARP cleavage and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="11" pm="."><plain>These results indicate that the activation of caspase family proteases is required for the apoptotic process induced by <z:chebi fb="0" ids="29035">Mn2+</z:chebi> treatment of B cells </plain></SENT>
<SENT sid="12" pm="."><plain>While the caspase-1 inhibitor YVAD was unable to block <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, the caspase-3 specific inhibitor DEVD-cmk, partially inhibited <z:chebi fb="0" ids="29035">Mn2+</z:chebi>-induced CPP32 activation, PARP cleavage and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of cells </plain></SENT>
<SENT sid="13" pm="."><plain>Moreover, Bcl-2 overexpression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-CL effectively protected cells from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> </plain></SENT>
<SENT sid="14" pm="."><plain>This is the first report showing the involvement of <z:chebi fb="0" ids="29035">Mn2+</z:chebi> in the regulation of B lymphocyte <z:hpo ids='HP_0011420'>death</z:hpo> presumably via a caspase-dependent process with a <z:hpo ids='HP_0011420'>death</z:hpo>-protective effect of Bcl-2 </plain></SENT>
</text></document>